ÂÜÀòÂÒÂ×

Julian Howell has extensive work experience in the pharmaceutical and biotechnology industry. Julian'smost recent role is as the CEO at LUNAC Therapeutics, a spin-out company from the University of Leeds focused on developing a first-in-class oral anticoagulant. Prior to this, Julian worked as a Clinical Development Consultant at Otadini Scientific Services and as a Co-Founder at PharmaKrysto Ltd, where they aimed to develop treatments for cystinuria. Julian also served as the Chief Medical Officer at ReNeuron and the Group Medical Director at Shield Therapeutics. Julian held a senior position as the Head of Clinical Development and Medical Affairs at ProStrakan, leading successful regulatory filings. Julian has additionally held roles at Pharmion, Chiron Biopharmaceuticals, LEO Pharma, and Roche Pharmaceuticals.

Julian Howell completed their MBA degree from Cranfield School of Management between 2000 and 2002. Prior to that, they pursued their MB BS degree at the University of London from 1984 to 1989. Julian'searlier education includes attending Wellington School in Somerset, UK from 1978 to 1983, although no specific degree or field of study is mentioned.